Deutsche Bank analyst Falko Friedrichs maintained a Sell rating on Evotec (0IRF – Research Report) today and set a price target of ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

FRANKFURT: Europe’s main stock index logged its best day in six weeks on Monday, with defence stocks in the lead ...

EUROPE’S main stock index logged its best day in six weeks on Monday, with defence stocks in the lead on prospects of higher ...

Triton Partners, is considering a takeover bid Evotec , Eyk Henning of Bloomberg reported earlier, citing people familiar with the matter. Triton is among several investment firms ...

Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer. Triton is among one of ...

European shares opened higher on Monday with most sectors rising, kicking off a week packed with global economic data ...

Germany-based Evotec SE (NASDAQ:EVO) is trading on Monday after a report that suggests the company is a takeover target. The ...

Evotec surged on Monday as it emerged that private equity firm Triton Partners is considering a takeover bid for the German drug development company after taking a near-10% stake.

(Bloomberg) -- Triton Partners is considering a takeover bid for Germany’s Evotec SE, according to people familiar with the matter, after the private equity firm emerged as one of the drug developer’s ...

European shares maintained gains on Monday as the post-US election rally continued, while Evotec shares surged on a report that private equity outfit Triton was mulling a bid for the German drug ...

Evotec confirmed to Reuters that Triton now holds a 9.99% stake in the company, making it its biggest shareholder, but said this had no impact on its day-to-day operations. Triton raised its stake to ...